INSYS Therapeutics Inc. (INSY)’s Financial Results Comparing With Verona Pharma plc (NASDAQ:VRNA)

Both INSYS Therapeutics Inc. (NASDAQ:INSY) and Verona Pharma plc (NASDAQ:VRNA) are Biotechnology companies, competing one another. We will contrast their dividends, analyst recommendations, profitability, risk, earnings and valuation, institutional ownership.

Valuation and Earnings

We can see in table 1 the earnings per share, top-line revenue and valuation of INSYS Therapeutics Inc. and Verona Pharma plc.

Profitability

Table 2 provides us INSYS Therapeutics Inc. and Verona Pharma plc’s return on assets, net margins and return on equity.

Analyst Ratings

The next table highlights the shown recommendations and ratings for INSYS Therapeutics Inc. and Verona Pharma plc.

INSYS Therapeutics Inc. has a consensus target price of $7.75, and a 831.49% upside potential.

Insider Institutional Ownership

The shares of both INSYS Therapeutics Inc. and Verona Pharma plc are owned by institutional investors at 18.9% and 65.7% respectively. Insiders held 63.83%

... read more at: https://stocksbeat.com/2019/06/04/trending-stock-news/insys-therapeutics-inc-insys-financial-results-comparing-with-verona-pharma-plc-nasdaqvrna/